The novel mouse Polo-like kinase 5 responds to DNA damage and localizes in the nucleolus

Nucleic Acids Research

Volumn 38, Issue 9, 2010, Pages 2931-2943

  Andrysik, Zdenek ^a,b   Bernstein, William Z ^a   Deng, Li ^c   Myer, David L ^a   Li, Ya Qin ^a   Tischfield, Jay A ^c   Stambrook, Peter J ^a   Bahassi, El Mustapha ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b INSTITUTE OF BIOPHYSICS   (Czech Republic)

^c RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLO LIKE KINASE; POLO LIKE KINASE 5; UNCLASSIFIED DRUG; POLO LIKE KINASE 5, HUMAN; POLO LIKE KINASE 5, MOUSE; POLO-LIKE KINASE 5, HUMAN; POLO-LIKE KINASE 5, MOUSE; PROTEIN P53; PROTEIN SERINE THREONINE KINASE;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CONTROLLED STUDY; DNA DAMAGE; DNA SEQUENCE; DNA SYNTHESIS; ENZYME LOCALIZATION; HUMAN; HUMAN CELL; NUCLEAR LOCALIZATION SIGNAL; NUCLEOLUS; PRIORITY JOURNAL; STOP CODON; ANIMAL; CELL CYCLE G1 PHASE; CELL LINE; CLASSIFICATION; ENZYMOLOGY; GENETICS; METABOLISM; MOLECULAR CLONING; MOUSE; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS;

ANIMALS; APOPTOSIS; CELL LINE; CELL NUCLEOLUS; CLONING, MOLECULAR; DNA DAMAGE; G1 PHASE; HUMANS; MICE; PROTEIN-SERINE-THREONINE KINASES; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77953242760     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkq011     Document Type: Article

References (70)

1. Lee, K.S., Grenfell, T.Z., Yarm, F.R. and Erikson, R.L. (1998) Mutation of the polo-box disrupts localization and mitotic functions of the mammalian polo kinase Plk. Proc. Natl Acad. Sci. USA, 95, 9301-9306.
2. Logarinho, E. and Sunkel, C.E. (1998) The Drosophila POLO kinase localises to multiple compartments of the mitotic apparatus and is required for the phosphorylation of MPM2 reactive epitopes. J. Cell Sci., 111(Pt 19), 2897-2909.
3. Shirayama, M., Zachariae, W., Ciosk, R. and Nasmyth, K. (1998) The Polo-like kinase Cdc5p and the WD-repeat protein Cdc20p/fizzy are regulators and substrates of the anaphase promoting complex in Saccharomyces cerevisiae. EMBO J., 17, 1336-1349.
4. Qian, Y.W., Erikson, E., Li, C. and Maller, J.L. (1998) Activated polo-like kinase Plx1 is required at multiple points during mitosis in Xenopus laevis. Mol. Cell Biol., 18, 4262-4271.
5. Moutinho-Santos, T., Sampaio, P., Amorim, I., Costa, M. and Sunkel, C.E. (1999) In vivo localisation of the mitotic POLO kinase shows a highly dynamic association with the mitotic apparatus during early embryogenesis in Drosophila. Biol. Cell, 91, 585-596.
6. Qian, Y.W., Erikson, E. and Maller, J.L. (1999) Mitotic effects of a constitutively active mutant of the Xenopus polo-like kinase Plx1. Mol. Cell Biol., 19, 8625-8632.
7. van de Weerdt, B.C., Littler, D.R., Klompmaker, R., Huseinovic, A., Fish, A., Perrakis, A. and Medema, R.H. (2008) Polo-box domains confer target specificity to the Polo-like kinase family. Biochim. Biophys. Acta, 1783, 1015-1022.
8. Lin, C.Y., Madsen, M.L., Yarm, F.R., Jang, Y.J., Liu, X. and Erikson, R.L. (2000) Peripheral Golgi protein GRASP65 is a target of mitotic polo-like kinase (Plk) and Cdc2. Proc. Natl Acad. Sci. USA, 97, 12589-12594.
9. Sutterlin, C., Lin, C.Y., Feng, Y., Ferris, D.K., Erikson, R.L. and Malhotra, V. (2001) Polo-like kinase is required for the fragmentation of pericentriolar Golgi stacks during mitosis. Proc. Natl Acad. Sci. USA, 98, 9128-9132.
10. Yarm, F.R. (2002) Plk phosphorylation regulates the microtubule-stabilizing protein TCTP. Mol. Cell Biol., 22, 6209-6221.
11. Elia, A.E., Cantley, L.C. and Yaffe, M.B. (2003) Proteomic screen finds pSer/pThr-binding domain localizing Plk1 to mitotic substrates. Science, 299, 1228-1231.
12. Elia, A.E., Rellos, P., Haire, L.F., Chao, J.W., Ivins, F.J., Hoepker, K., Mohammad, D., Cantley, L.C., Smerdon, S.J. and Yaffe, M.B. (2003) The molecular basis for phosphodependent substrate targeting and regulation of Plks by the Polo-box domain. Cell, 115, 83-95.
13. Neef, R., Preisinger, C., Sutcliffe, J., Kopajtich, R., Nigg, E.A., Mayer, T.U. and Barr, F.A. (2003) Phosphorylation of mitotic kinesin-like protein 2 by polo-like kinase 1 is required for cytokinesis. J. Cell Biol., 162, 863-875.
14. Zhou, T., Aumais, J.P., Liu, X., Yu-Lee, L.Y. and Erikson, R.L. (2003) A role for Plk1 phosphorylation of NudC in cytokinesis. Dev. Cell, 5, 127-138.
15. Liu, X., Zhou, T., Kuriyama, R. and Erikson, R.L. (2004) Molecular interactions of Polo-like-kinase 1 with the mitotic kinesin-like protein CHO1/MKLP-1. J. Cell Sci., 117, 3233-3246.
16. Lane, H.A. and Nigg, E.A. (1996) Antibody microinjection reveals an essential role for human polo-like kinase 1 (Plk1) in the functional maturation of mitotic centrosomes. J. Cell Biol., 135, 1701-1713.
17. do Carmo Avides, M., Tavares, A. and Glover, D.M. (2001) Polo kinase and Asp are needed to promote the mitotic organizing activity of centrosomes. Nat. Cell Biol., 3, 421-424.
18. Golsteyn, R.M., Schultz, S.J., Bartek, J., Ziemiecki, A., Ried, T. and Nigg, E.A. (1994) Cell cycle analysis and chromosomal localization of human Plk1, a putative homologue of the mitotic kinases Drosophila polo and Saccharomyces cerevisiae Cdc5. J. Cell Sci., 107(Pt 6), 1509-1517.
19. Lee, K.S., Yuan, Y.L., Kuriyama, R. and Erikson, R.L. (1995) Plk is an M-phase-specific protein kinase and interacts with a kinesin-like protein, CHO1/MKLP-1. Mol. Cell Biol., 15, 7143-7151.
20. Song, S., Grenfell, T.Z., Garfield, S., Erikson, R.L. and Lee, K.S. (2000) Essential function of the polo box of Cdc5 in subcellular localization and induction of cytokinetic structures. Mol. Cell Biol., 20, 286-298.
21. Barr, F.A., Sillje, H.H. and Nigg, E.A. (2004) Polo-like kinases and the orchestration of cell division. Nat. Rev. Mol. Cell Biol., 5, 429-440.
22. Fabbro, D. and Garcia-Echeverria, C. (2002) Targeting protein kinases in cancer therapy. Curr. Opin. Drug Discov. Dev., 5, 701-712.
23. Noble, M.E., Endicott, J.A. and Johnson, L.N. (2004) Protein kinase inhibitors: insights into drug design from structure. Science, 303, 1800-1805.
24. Stout, T.J., Foster, P.G. and Matthews, D.J. (2004) High-throughput structural biology in drug discovery: protein kinases. Curr. Pharm. Des., 10, 1069-1082.
25. Lenart, P., Petronczki, M., Steegmaier, M., Di Fiore, B., Lipp, J.J., Hoffmann, M., Rettig, W.J., Kraut, N. and Peters, J.M. (2007) The small-molecule inhibitor BI 2536 reveals novel insights into mitotic roles of polo-like kinase 1. Curr. Biol., 17, 304-315.
26. Steegmaier, M., Hoffmann, M., Baum, A., Lenart, P., Petronczki, M., Krssak, M., Gurtler, U., Garin-Chesa, P., Lieb, S., Quant, J. et al. (2007) BI 2536, a potent and selective inhibitor of polo-like kinase 1, inhibits tumor growth in vivo. Curr. Biol., 17, 316-322.
27. Donohue, P.J., Alberts, G.F., Guo, Y. and Winkles, J.A. (1995) Identification by targeted differential display of an immediate early gene encoding a putative serine/threonine kinase. J. Biol. Chem., 270, 10351-10357.
28. Xie, S., Wu, H., Wang, Q., Cogswell, J.P., Husain, I., Conn, C., Stambrook, P., Jhanwar-Uniyal, M. and Dai, W. (2001) Plk3 functionally links DNA damage to cell cycle arrest and apoptosis at least in part via the p53 pathway. J. Biol. Chem., 276, 43305-43312.
29. Bahassi el, M., Conn, C.W., Myer, D.L., Hennigan, R.F., McGowan, C.H., Sanchez, Y. and Stambrook, P.J. (2002) Mammalian Polo-like kinase 3 (Plk3) is a multifunctional protein involved in stress response pathways. Oncogene, 21, 6633-6640.
30. Xie, S., Wu, H., Wang, Q., Kunicki, J., Thomas, R.O., Hollingsworth, R.E., Cogswell, J. and Dai, W. (2002) Genotoxic stress-induced activation of Plk3 is partly mediated by Chk2. Cell Cycle, 1, 424-429.
31. Matthew, E.M., Yen, T.J., Dicker, D.T., Dorsey, J.F., Yang, W., Navaraj, A. and El-Deiry, W.S. (2007) Replication stress, defective S-phase checkpoint and increased death in Plk2-deficient human cancer cells. Cell Cycle, 6, 2571-2578.
32. Simmons, D.L., Neel, B.G., Stevens, R., Evett, G. and Erikson, R.L. (1992) Identification of an early-growth-response gene encoding a novel putative protein kinase. Mol. Cell Biol., 12, 4164-4169.
33. Liby, K., Wu, H., Ouyang, B., Wu, S., Chen, J. and Dai, W. (2001) Identification of the human homologue of the early-growth response gene Snk, encoding a serum-inducible kinase. DNA Seq., 11, 527-533.
34. Ma, S., Charron, J. and Erikson, R.L. (2003) Role of Plk2 (Snk) in mouse development and cell proliferation. Mol. Cell Biol., 23, 6936-6943.
35. Hudson, J.W., Chen, L., Fode, C., Binkert, C. and Dennis, J.W. (2000) Sak kinase gene structure and transcriptional regulation. Gene, 241, 65-73.
36. Hudson, J.W., Kozarova, A., Cheung, P., Macmillan, J.C., Swallow, C.J., Cross, J.C. and Dennis, J.W. (2001) Late mitotic failure in mice lacking Sak, a polo-like kinase. Curr. Biol., 11, 441-446.
37. Leung, G.C., Hudson, J.W., Kozarova, A., Davidson, A., Dennis, J.W. and Sicheri, F. (2002) The Sak polo-box comprises a structural domain sufficient for mitotic subcellular localization. Nat. Struct. Biol., 9, 719-724.
38. Bahassi el, M., Myer, D.L., McKenney, R.J., Hennigan, R.F. and Stambrook, P.J. (2006) Priming phosphorylation of Chk2 by polo-like kinase 3 (Plk3) mediates its full activation by ATM and a downstream checkpoint in response to DNA damage. Mutat. Res., 596, 166-176.
39. Yang, Y., Bai, J., Shen, R., Brown, S.A., Komissarova, E., Huang, Y., Jiang, N., Alberts, G.F., Costa, M., Lu, L. et al. (2008) Polo-like kinase 3 functions as a tumor suppressor and is a negative regulator of hypoxia-inducible factor-1 alpha under hypoxic conditions. Cancer Res., 68, 4077-4085.
40. Zimmerman, W.C. and Erikson, R.L. (2007) Polo-like kinase 3 is required for entry into S phase. Proc. Natl Acad. Sci. USA, 104, 1847-1852.
41. Chase, D., Feng, Y., Hanshew, B., Winkles, J.A., Longo, D.L. and Ferris, D.K. (1998) Expression and phosphorylation of fibroblast-growth-factor-inducible kinase (Fnk) during cell-cycle progression. Biochem. J., 333(Pt 3), 655-660.
42. Smits, V.A., Klompmaker, R., Arnaud, L., Rijksen, G., Nigg, E.A. and Medema, R.H. (2000) Polo-like kinase-1 is a target of the DNA damage checkpoint. Nat. Cell Biol., 2, 672-676.
43. Bahassi el, M., Penner, C.G., Robbins, S.B., Tichy, E., Feliciano, E., Yin, M., Liang, L., Deng, L., Tischfield, J.A. and Stambrook, P.J. (2007) The breast cancer susceptibility allele CHEK2*1100delC promotes genomic instability in a knock-in mouse model. Mutat. Res., 616, 201-209.
44. Bahassi el, M., Hennigan, R.F., Myer, D.L. and Stambrook, P.J. (2004) Cdc25C phosphorylation on serine 191 by Plk3 promotes its nuclear translocation. Oncogene, 23, 2658-2663.
45. Lee, K.S. and Erikson, R.L. (1997) Plk is a functional homolog of Saccharomyces cerevisiae Cdc5, and elevated Plk activity induces multiple septation structures. Mol. Cell Biol., 17, 3408-3417.
46. Ouyang, B., Li, W., Pan, H., Meadows, J., Hoffmann, I. and Dai, W. (1999) The physical association and phosphorylation of Cdc25C protein phosphatase by Prk. Oncogene, 18, 6029-6036.
47. Smith, M.R., Wilson, M.L., Hamanaka, R., Chase, D., Kung, H., Longo, D.L. and Ferris, D.K. (1997) Malignant transformation of mammalian cells initiated by constitutive expression of the polo-like kinase. Biochem. Biophys. Res. Commun., 234, 397-405.
48. Conn, C.W., Hennigan, R.F., Dai, W., Sanchez, Y. and Stambrook, P.J. (2000) Incomplete cytokinesis and induction of apoptosis by overexpression of the mammalian polo-like kinase, Plk3. Cancer Res., 60, 6826-6831.
49. Sumara, I., Gimenez-Abian, J.F., Gerlich, D., Hirota, T., Kraft, C., de la Torre, C., Ellenberg, J. and Peters, J.M. (2004) Roles of polo-like kinase 1 in the assembly of functional mitotic spindles. Curr. Biol., 14, 1712-1722.
50. Hanisch, A., Wehner, A., Nigg, E.A. and Sillje, H.H. (2006) Different Plk1 functions show distinct dependencies on Polo-Box domain-mediated targeting. Mol. Biol. Cell, 17, 448-459.
51. Busch, H., Muramatsu, M., Adams, H., Steele, W.J., Liau, M.C. and Smetana, K. (1963) Isolation of nucleoli. Exp Cell Res., 24(Suppl. 9), 150-163.
52. Blackshaw, S., Harpavat, S., Trimarchi, J., Cai, L., Huang, H., Kuo, W.P., Weber, G., Lee, K., Fraioli, R.E., Cho, S.H. et al. (2004) Genomic analysis of mouse retinal development. PLoS Biol., 2, E247.
53. Roesch, K., Jadhav, A.P., Trimarchi, J.M., Stadler, M.B., Roska, B., Sun, B.B. and Cepko, C.L. (2008) The transcriptome of retinal Müller glial cells. J. Comp. Neurol., 509, 225-238.
54. Lowery, D.M., Lim, D. and Yaffe, B. (2005) Structure and function of Polo-like kinases. Oncogene, 24, 248-259.
55. Lu, L.Y., Wood, J.L., Minter-Dykhouse, K., Ye, L., Saunders, T.L., Yu, X. and Chen, J. (2008) Polo-like kinase 1 is essential for early embryonic development and tumor suppression. Mol. Cell Biol., 28, 6870-6876.
56. Ma, S., Charron, J. and Erikson, R.L. (2003) Role of Plk2 (Snk) in mouse development and cell proliferation. Mol. Cell Biol., 23, 6936-6943.
57. Haren, L., Stearns, T. and Lüders, J. (2009) Plk1-dependent recruitment of gamma-tubulin complexes to mitotic centrosomes involves multiple PCM components. PLoS ONE, 4, e5976.
58. Wsierska-Gadek, J. and Horky, M. (2003) How the nucleolar sequestration of p53 protein or its interplayers contributes to its (re)-activation. Ann. NY Acad. Sci., 1010, 266-272.
59. Cerutti, L. and Simanis, V. (2000) Controlling the end of the cell cycle. Curr. Opin. Genet. Dev., 10, 65-69.
60. Mekhail, K., Khacho, M., Carrigan, A., Hache, R.R., Gunaratnam, L. and Lee, S. (2005) Regulation of ubiquitin ligase dynamics by the nucleolus. J. Cell Biol., 170, 733-744.
61. Argentini, M., Barboule, N. and Wasylyk, B. (2000) The contribution of the RING finger domain of MDM2 to cell cycle progression. Oncogene, 19, 3849-3857.
62. Rogalsky, V., Todorov, G. and Moran, D. (1993) Translocation of retinoblastoma protein associated with tumor cell growth inhibition. Biochem. Biophys. Res. Commun., 192, 1139-1146.
63. Zini, N., Trimarchi, C., Claudio, P.P., Stiegler, P., Marinelli, F., Maltarello, M.C., La Sala, D., De Falco, G., Russo, G., Ammirati, G. et al. (2001) pRb2/p130 and p107 control cell growth by multiple strategies and in association with different compartments within the nucleus. J. Cell Physiol., 189, 34-44.
64. Green, C., Chatterjee, R., McGarrigle, H.H., Ahmed, F. and Thomas, N.S. (2000) p107 is active in the nucleolus in non-dividing human granulosa lutein cells. J. Mol. Endocrinol., 25, 275-286.
65. Rizos, H., Darmanian, A.P., Mann, G.J. and Kefford, R.F. (2000) Two arginine rich domains in the p14ARF tumour suppressor mediate nucleolar localization. Oncogene, 19, 2978-2985.
66. Nishikimi, M., Fukuyama, R., Minoshima, S., Shimizu, N. and Yagi, K. (1994) Cloning and chromosomal mapping of the human nonfunctional gene for L-gulono-gamma-lactone oxidase, the enzyme for L-ascorbic acid biosynthesis missing in man. J. Biol. Chem., 269, 13685-13688.
67. Wu, X.W., Lee, C.C., Muzny, D.M. and Caskey, C.T. (1989) Urate oxidase: primary structure and evolutionary implications. Proc. Natl Acad. Sci. USA, 86, 9412-9416.
68. Edgar, A.J. (2002) The human L-threonine 3-dehydrogenase gene is an expressed pseudogene. BMC Genet., 3, 18.
69. Wang, J., Alexander, P., Wu, L., Hammer, R., Cleaver, O. and McKnight, S.L. (2009) Dependence of mouse embryonic stem cells on threonine catabolism. Science, 325, 435-439.
70. Felsenstein, J. (1997) An alternating least squares approach to inferring phylogenies from pairwise distances. Syst. Biol., 46, 101-111.